Addus HomeCare (NASDAQ:ADUS) EVP David Tucker Sells 14,850 Shares of Company Stock

Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP David Tucker sold 14,850 shares of the stock in a transaction on Friday, November 6th. The stock was sold at an average price of $124.75, for a total value of $1,852,537.50. Following the completion of the transaction, the executive vice president directly owned 8,073 shares in the company, valued at $1,007,106.75. This trade represents a 64.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Addus HomeCare Price Performance

ADUS stock opened at $126.29 on Wednesday. The stock has a 50-day moving average price of $117.97 and a two-hundred day moving average price of $107.02. Addus HomeCare Corporation has a 12-month low of $87.95 and a 12-month high of $131.59. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.02. The company has a market cap of $2.35 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 1.62 and a beta of 0.75.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.83 EPS for the quarter, topping the consensus estimate of $1.79 by $0.04. The company had revenue of $387.74 million during the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a return on equity of 10.22% and a net margin of 7.39%. The firm’s revenue was up 7.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.56 earnings per share. As a group, research analysts predict that Addus HomeCare Corporation will post 6.36 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently issued reports on ADUS. Weiss Ratings raised shares of Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, September 24th. Barclays raised their price target on shares of Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a report on Wednesday, November 4th. UBS Group lifted their price target on shares of Addus HomeCare from $145.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Raymond James Financial set a $137.00 price objective on shares of Addus HomeCare in a research note on Monday, September 28th. Finally, TD Cowen boosted their price objective on shares of Addus HomeCare from $131.00 to $145.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Seven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Addus HomeCare presently has an average rating of “Moderate Buy” and an average target price of $134.70.

Get Our Latest Stock Analysis on Addus HomeCare

Trending Headlines about Addus HomeCare

Here are the key news stories impacting Addus HomeCare this week:

  • Neutral Sentiment: Addus said it will participate in the 2026 Stephens Annual Investment Conference. The announcement provides an opportunity to meet investors but gives no new financial or operating guidance. Article: Addus HomeCare to Participate in 2026 Stephens Annual Investment Conference
  • Neutral Sentiment: A report listed short interest at zero shares, indicating no reported short position; however, its description of a “large increase” conflicts with that figure.
  • Negative Sentiment: Several executives disclosed stock sales. CEO R. Allison sold 98,958 shares for about $12.2 million, reducing his holding by 35.08%. Five EVPs collectively sold 32,697 shares for roughly $4.1 million. Insider sales can weigh on sentiment, although they do not by themselves establish a negative outlook. CEO sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing EVP sale filing

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the stock. NFJ Investment Group LLC purchased a new stake in shares of Addus HomeCare in the second quarter worth about $29,000. Parallel Advisors LLC grew its stake in shares of Addus HomeCare by 66.3% in the first quarter. Parallel Advisors LLC now owns 404 shares of the company’s stock valued at $38,000 after buying an additional 161 shares in the last quarter. Heritage Family Offices LLP acquired a new stake in shares of Addus HomeCare in the third quarter valued at about $43,000. Hantz Financial Services Inc. raised its holdings in shares of Addus HomeCare by 21.3% during the 3rd quarter. Hantz Financial Services Inc. now owns 620 shares of the company’s stock valued at $69,000 after buying an additional 109 shares during the period. Finally, State of Wyoming purchased a new stake in shares of Addus HomeCare during the 2nd quarter valued at about $79,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

About Addus HomeCare

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

Featured Articles

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.